Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial.
Cancer Immunol Immunother
; 65(11): 1395-1400, 2016 11.
Article
en En
| MEDLINE
| ID: mdl-27604993
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Nasales
/
Inmunoterapia
/
Melanoma
/
Anticuerpos Monoclonales
/
Mucosa Nasal
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
Límite:
Aged
/
Female
/
Humans
Idioma:
En
Año:
2016
Tipo del documento:
Article